Supplementary Data from Combining Neratinib with CDK4/6, Mtor, and MEK Inhibitors in Models of HER2-positive Cancer
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined